top of page
© 2021 by PressCise AB
© 2021 by PressCise AB
© 2021 by PressCise AB
-
Shorter wound healing times compared to conventional compression bandaging.
-
Estimated over 50% less visits to clinics thanks to maintenance of pressure and improved self-care.
-
No re-fitting of products needed thanks to the maintened pressure.
-
Low and safe pressure allows for compression treatment of impaired
arterial circulation and type 2 diabetes patients.
Our team
Felix Shönle
Chairman of the Board
Chief Executive Officer,
Wernli AG Verbandstoffe.
Josefin Damm
Chief Technology Officer
Co-inventor and co-founder of PressCise AB.
Possesses extensive experience in smart and technical textile product development, business development, and project management.
.png)
Katja Schönle
Deputy Board Member
Head of Sales,
Wernli AG Verbandstoffe.
bottom of page